1. Home
  2. EVAX vs BREA Comparison

EVAX vs BREA Comparison

Compare EVAX & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • BREA
  • Stock Information
  • Founded
  • EVAX 2008
  • BREA 2022
  • Country
  • EVAX Denmark
  • BREA Ireland
  • Employees
  • EVAX N/A
  • BREA N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • EVAX Health Care
  • BREA Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • BREA Nasdaq
  • Market Cap
  • EVAX 8.7M
  • BREA 8.7M
  • IPO Year
  • EVAX 2021
  • BREA 2023
  • Fundamental
  • Price
  • EVAX $2.62
  • BREA $0.64
  • Analyst Decision
  • EVAX Strong Buy
  • BREA
  • Analyst Count
  • EVAX 3
  • BREA 0
  • Target Price
  • EVAX $33.33
  • BREA N/A
  • AVG Volume (30 Days)
  • EVAX 6.8M
  • BREA 61.2K
  • Earning Date
  • EVAX 03-26-2025
  • BREA 01-03-2025
  • Dividend Yield
  • EVAX N/A
  • BREA N/A
  • EPS Growth
  • EVAX N/A
  • BREA N/A
  • EPS
  • EVAX N/A
  • BREA N/A
  • Revenue
  • EVAX $3,295,000.00
  • BREA $2,872,101.00
  • Revenue This Year
  • EVAX $4,845.21
  • BREA N/A
  • Revenue Next Year
  • EVAX $30.30
  • BREA N/A
  • P/E Ratio
  • EVAX N/A
  • BREA N/A
  • Revenue Growth
  • EVAX N/A
  • BREA 2338.69
  • 52 Week Low
  • EVAX $2.22
  • BREA $0.50
  • 52 Week High
  • EVAX $23.70
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.09
  • BREA 40.04
  • Support Level
  • EVAX $2.22
  • BREA $0.62
  • Resistance Level
  • EVAX $4.05
  • BREA $0.69
  • Average True Range (ATR)
  • EVAX 1.17
  • BREA 0.05
  • MACD
  • EVAX 0.00
  • BREA -0.01
  • Stochastic Oscillator
  • EVAX 6.99
  • BREA 15.31

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: